Transformed Lymphoma
📧 Sign up to get email alerts when something new happens for Transformed Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
Clinical trial update reporting on neurocognitive effects and patient-reported outcomes for axicabtagene ciloleucel in diffuse large B-cell …
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma [Phase 1]
A Phase 1 exploratory study evaluated CD19-targeted CAR T cells (BZ019) in relapsed/refractory B-cell lymphomas, including diffuse large B-c…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma [Phase 2]
Phase 2 protocol update for DLCL002 in high-risk aggressive B-cell lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL [Phase 1, Phase 2]
Phase 1/2 trial evaluating tislelizumab plus lenalidomide in refractory/relapsed elderly patients with various aggressive B-cell lymphomas, …
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial results evaluating rituximab after autologous stem cell transplant in relapsed B-cell non-Hodgkin lymphoma have been completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.